BDNF and CGRP interaction: implications in migraine susceptibility

Cephalalgia. 2010 Nov;30(11):1375-82. doi: 10.1177/0333102410368443. Epub 2010 May 10.

Abstract

Objectives: Migraine pathophysiology involves several pathways. Our aims were to explore a possible role of the brain-derived neurotrophic factor gene (BDNF) in migraine susceptibility; to study, for the first time, the calcitonin gene-related peptide gene (CGRP); and a possible interaction between the two.

Methods: Using a case-control approach, four tagging single nucleotide polymorphisms (SNPs) (rs7124442, rs6265, rs11030107, and rs2049046) of BDNF and one tagging SNP-rs1553005-of CGRP were analyzed in 188 cases and 287 controls. A multivariable logistic regression was performed, adjusting for gender. Allelic and haplotypic frequencies were estimated. Interaction was assessed by a stepwise multivariable-logistic regression and confirmed by a multifactor dimensionality reduction analysis.

Results: No significant main effects were found; however, a significant interaction was found between BDNF and CGRP, showing an increased risk for the AT-genotype of rs2049046 and the GC-genotype of rs1553005 (odds ratio=1.88, 95% confidence interval: 1.20-2.93) for migraineurs.

Conclusion: Our data support the hypothesis of an interaction between BDNF and CGRP in migraine susceptibility that should be further explored.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Brain-Derived Neurotrophic Factor / genetics*
  • Calcitonin Gene-Related Peptide / genetics*
  • Case-Control Studies
  • Epistasis, Genetic
  • Female
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Male
  • Migraine Disorders / genetics*
  • Multifactor Dimensionality Reduction
  • Polymorphism, Single Nucleotide
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Brain-Derived Neurotrophic Factor
  • Calcitonin Gene-Related Peptide